The manufacturer of the Russian vaccine “Kovivak” filed a request for the registration of the drug in South Korea. This is reported by Reuters with reference to the statement of the Ministry of Health of the Republic.
So far, the South Korean authorities do not plan to procure the drug.
Kovivak vaccine developed the center of Chumakov, she entered the civil turnover at the beginning of the summer of the current year. According to developers, immunity to COVID-19 after the use of the drug is saved about eight months.
/Media reports.